What is LBRX's change in AP?

LBRX (LBRX) reported change in AP of $3.46M in Q1 2026.

How has LBRX's change in AP changed year-over-year?

LBRX's change in AP increased by 219.7% year-over-year, from -$2.89M to $3.46M.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

LBRX LBRX Change in AP

Change in AP at other companies

Bristol-Myers SquibbBMY

$409M+581%

AlkermesALKS

-$119.47M-7,007%

MapLight Therapeutics, Inc. MPLT

-$111K+89.4%

Alto NeuroscienceANRO

$1.49M+660%

Zevra Therapeutics, Inc.ZVRA

-$529K+92.7%

Opko HealthOPK

$3.5M-69.5%

Other financials

Income statement

See full

Net income-$19.1M-259%

EPS (diluted)-$0.67+95.5%

Balance sheet

See full

Cash & equivalents$320.7M—

Total debt$3.5M—

Total equity$378.7M+481%

Total assets$393.5M—

Cash flow

See full

Operating cash flow-$23.3M-187%

CapEx$32.0K+52.4%

Free cash flow-$23.3M-186%

Valuation

See full

Market cap$888.98M+163%

Enterprise value$571.77M—

Returns & leverage

See full

Return on equity-27.9%—

Debt / equity0×—

Current ratio35.7×—

Where this comes from

Reported directly by LBRX in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.

The official record: LBRX’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about LBRX's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is LBRX's change in AP?: LBRX (LBRX) reported change in AP of $3.46M in Q1 2026.
How has LBRX's change in AP changed year-over-year?: LBRX's change in AP increased by 219.7% year-over-year, from -$2.89M to $3.46M.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.